Caliway Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Caliway Biopharmaceuticals Co., Ltd., explained in plain language.
A Taiwan-based biopharmaceutical company developing treatments for inflammatory and fibrotic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New injection aims to melt belly fat without surgery Results expected Apr 2027 (estimated)
- Belly fat melting shot? phase 3 trial begins. Results expected May 2027 (estimated) 🚀 Make-or-break
- New shot aims to melt belly fat without surgery Results expected Aug 2027 (estimated) 🚀 Make-or-break